Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT
- DOI
- 10.1158/1535-7163.mct-05-0445
- Published
- 2006-05-01
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-05-0445,
title = {Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT},
author = {Nivedita Sain and Bhavani Krishnan and Michael G. Ormerod and Assunta De Rienzo and Wai M. Liu and Stanley B. Kaye and Paul Workman and Ann L. Jackman},
year = {2006},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-05-0445},
url = {https://doi.org/10.1158/1535-7163.mct-05-0445}
}RIS
TY - JOUR TI - Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT AU - Nivedita Sain AU - Bhavani Krishnan AU - Michael G. Ormerod AU - Assunta De Rienzo AU - Wai M. Liu AU - Stanley B. Kaye AU - Paul Workman AU - Ann L. Jackman PY - 2006 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-05-0445 UR - https://doi.org/10.1158/1535-7163.mct-05-0445 ER -
APA
Sain, N., Krishnan, B., Ormerod, M. G., Rienzo, A. D., Liu, W. M., Kaye, S. B., Workman, P., & Jackman, A. L. (2006). Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-05-0445
Source records
- crossref · retrieved 2026-09-26T10:17:52.002Z